DONATE

Search Results for:

Gran èxit del 13è simposi anual de l’IBEC

L’Institut de Bioenginyeria de Catalunya (IBEC) va organitzar del 27 al 28 d’octubre el seu 13è Simposi. L’esdeveniment, que aquest any va tenir lloc per primera vegada en línia, es va centrar en la Bioenginyeria per a la Medicina del Futur i de Precisió. Amb més de 400 assistents inscrits, 18 flash presentations i 106 pòsters, l’esdeveniment també va comptar amb les contribucions de ponents internacionals de primer nivell com Robert Langer del MIT, Ada Cavalcanti de la Universitat de Heidelberg o Raquel Yotti, directora de l’Institut de Salut Carlos III , entre altres.

Online IBEC Seminar: Xavier Trepat

Mechanobiology of intestinal organoids Xavier Trepat, IBEC Intestinal organoids capture essential features of the intestinal epithelium such as folding of the crypt, spatial compartmentalization of different cell types, and cellular … Read more

13th annual IBEC symposium on the media

Various media have reported on the opening of the 13th annual IBEC symposium, conducted by Josep Samitier, Director of IBEC, Robert Fabregat, General Director of Research and Innovation in Health of the Ministry of Health at Generalitat of Catalunya; Alfredo González Gómez, Secretary General of Digital Health, Information and Innovation from the Spanish Ministry of Health and Professor Francesc Torres, rector of the UPC.

PhD Position in the Synthetic Morphogenesis group (IBEC, TU/e)


Application Deadline: 15/12/2020
Ref: PH- VC

The Institute for Bioengineering of Catalonia (IBEC) in collaboration with the Eindhoven University of Technology (TU/e, Eindhoven – Netherlands) are seeing an ambitious PhD Candidate to investigate the morphogenesis of living tissues from the computational perspective. The successful candidate will carry out computational research with the Synthetic Morphogenesis group under the supervision of Dr Vito Conte across both institutions at the interface between Biology, Physics, Engineering, Mathematics and Computer Sciences. This multidisciplinary doctoral research will be carried out in collaboration with Dr Jose Muñoz at the Polytechnic University of Catalonia (UPC, Barcelona – Spain) and will be part of greater efforts aiming at establishing a new Platform for the Live-Quantification of Cell and Tissue Mechanics across the IBEC and the TU/e.

The Edison of medicine visits IBEC

The Institute for Bioengineering of Catalonia (IBEC) invites Robert Langer, and other renowned international speakers, to its annual symposium to talk about how bioengineering can shape the future of precision medicine. Langer, Professor of the Technological Institute of Massachusetts (MIT), and Director of its biomedical engineering laboratory, is considered the father of intelligent drugs delivery, the most cited engineer in the world but, especially, a global pioneer with over thousand patents and promoter of dozens of companies with great projection, which has earned him the nickname of “The Edison of Medicine”. 

Electric forces to characterize future biocompatible organic electronic devices

A joint collaboration between the Institute for Bioengineering of Catalonia (IBEC), the Institute of Materials Science of Barcelona (ICMAB) and The University of Manchester has succeeded in mapping the electrical properties of organic biosensor/electrolyte interfaces at the nanoscale by measuring local electric forces. Electronic biosensors based on organic materials could make soon a reality the dream of low-cost, disposable, flexible and biocompatible electronic devices for the interaction with biological systems .

Predoctoral Researcher at the Nanoprobes & Nanoswitches Research Group


Application Deadline: 20/10/2021
Ref: PhD-PG

The nanoprobes group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Predoctoral Researcher to develop synthetic photochromic compounds for the manipulation of ion channels and receptors. The contract will be within the framework of ongoing projects of the laboratory, whose objectives include both fundamental investigation of neuronal circuits and novel therapeutic developments for sensory restoration, and against excitatory/inhibitory disbalances in the central nervous system such as epilepsy.